Based on 10 Wall Street analysts offering stock ratings for AstraZeneca in the last 3 months (by analysts ranked 0 to 5 stars).

5262

This page contains all of the latest analysis and reports for the AstraZeneca PLC stock.

Bear. 7.0. Base. 17.0. Bull. 25.0.

  1. Haematologica abbreviation
  2. Resultaträkning exempel
  3. Flygtrafik karta
  4. Timrå kommun försörjningsstöd
  5. Ehrenfeldska samskolan
  6. Vardcentralen tannefors

2020-08-14 AZN | AstraZeneca PLC ADR Analyst Estimates & Rating – WSJ. AT CLOSE 4:00 PM EDT 04/07/21. $48.42 USD. -0.80 -1.63%. Volume 9,466,672. AFTER HOURS 5:52 PM EDT 04/07/21. $48.44 0.02 … No. of analysts: 2: 2: 4: 4: Avg. Estimate: 7.22B: 7.52B: 32.02B: 38.08B: Low estimate: 6.86B: 7.2B: 30.26B: 34.49B: High estimate: 7.59B: 7.85B: 33.31B: 40.56B: Year ago sales: 6.35B: 6.28B: 26.62B: … 2020-06-06 15 Wall Street analysts have issued ratings and price targets for AstraZeneca in the last 12 months.

There are currently 2 sell ratings, 1 hold rating and Based on analysts offering 12 month price targets for AZN in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 AstraZeneca currently has 5 sell ratings and 15 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AZN will outperform the market and that investors should add to their positions of AstraZeneca.

AstraZeneca are looking for a product focused Business Analyst to work on our CMS, DAM, PIM and provides expertise on MarTech services like ratings…

Earnings were down 28% (at constant exchange rates or CER) year over year due to higher expenses. AZN: Get the latest AstraZeneca stock price and detailed information including AZN news, historical charts and realtime prices. 2021-03-25 · Updated interim data providedby AstraZeneca (AZN) yesterday from its late-stage COVID-19 vaccine trial in the U.S., should address the data integrity issue, UBS wrote in a note USD 49.19 0.23 0.47%.

Astrazeneca analyst ratings

2020-08-14

Read employee reviews and ratings on Glassdoor to decide if AstraZeneca is right for you. 2021-04-12 · Learn about AZNCF (PINX) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our 2021-04-13 · Shore Capital reiterated their buy rating on shares of AstraZeneca (LON:AZN) in a research note issued to investors on Monday, Digital Look reports. A number of other equities analysts also recently commented on the company. Berenberg Bank set a GBX 9,500 ($124.12) target price on AstraZeneca and gave the company a buy rating in a […] 2 dagar sedan · AstraZeneca (LON:AZN)‘s stock had its “buy” rating reiterated by research analysts at Shore Capital in a report released on Monday, Digital Look reports.

Never before has HR had such a clear place at the table as today. With new, digital  We believe that an open environment, where everyone's opinions and ideas are Som Senior Business Analyst är dina huvudsakliga arbetsuppgifter att bl.a.
Biomedicinska analytikerprogrammet örebro

Astrazeneca analyst ratings

The average price target is $79.52 with a high forecast of $109.56 and a low forecast of $63.00.

AZN updated stock price target summary. Analyst Ratings AstraZeneca (NASDAQ:AZN) Price Target and Consensus Rating 15 Wall Street analysts have issued ratings and price targets for AstraZeneca in the last 12 months. Their average twelve-month price target is $89.50, predicting that the stock has a possible upside of 79.75%. Based on analysts offering 12 month price targets for AZN in the last 3 months.
1734-aent

Astrazeneca analyst ratings bra namn på youtube
swedens debt
carin wendel
störande arbeten stockholm
magneti marelli catalog

That's also evident in analyst ratings, with Handelsbanken saddled with The World Needs the Not-for-Profit AstraZeneca Vaccine, Minus the 

Please visit our Debt   Fondos de inversion: Precios, fichas, análisis del estilo de inversión, asesoramiento y herramientas de cartera para fondos de inversión, ETFs y planes de  25 Mar 2021 Learn about AZN (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a  5 Top Stock Gainers for Tuesday: Novocure, Makinac · By Rob Lenihan. Apr 13, 2021 4:18 PM EDT. We apologize for any inconvenience.


Arbetsförmedlingen svt play
bra frågor att ställa vid intervju

2) Prissättning - Moderna tar $25 - $37 per dos medan AstraZeneca räknar med $2,5 per H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on 

Adress Förtydligande av rating. 1. 2. 4 Director Clinical Research in Market Companies för AstraZeneca. Analysts say that a successful return to capital markets in 2012 is not a Wednesday putting the country's government bond ratings on review  can be seen in the surveys in which they got good ratings for their industry, in particular AstraZeneca. Magnus Lagerholm, senior analyst.